Sports

Shareholder are not always happy campers, but a new press release issued by one of ConMed’s institutional investors has been written in such a coruscatingly damning tone that we thought it worthy of presentation to our audience of cultured types who appreciate a bit of literary creativity. Not sure ConMed will be quite so appreciative.

A changing sales mix, the impact of the US sales tax and ongoing increased provision for potential settlement of outstanding alleged stock fraud all contributed to ArthroCare’s lower than predicted earnings. This, despite healthy top line sales growth in Q3.

Parametrics Medical, LLC, a private tissue bank has announced its release of its Coll-e-Strong line of soft tissue allografts. Using E-Beam Technology, to terminally sterilize the tissue without compromising the biomechanical properties of the collagen, the company claims its allograft line is the first to bridge the gap between biomechanics and sterility.

It’s AAOS week, and Mitek Sports Medicine has chosen the event for the launch of the MILAGRO® Advance Interference Screw, a new biocomposite screw designed to offer easier and faster insertion when compared to traditional interference screws.

Even without the revenue following the acquisition of DePuy’s trauma business, Biomet’s SET products showed impressive double digit growth. Joints nudged up too, but it’s SET that has underpinned the company’s positive sales momentum.

Biomet has released its financial results for the most recent quarter, showing a net sales increase of 9% compared with a year ago. Income and earnings showed similarly healthy increases, although one-off costs translated into a significantly bigger net loss than in the equivalent period.

Covidien must be hoping surgeons will see the benefit of simplicity in its new meniscal repair device which has the retro feel of the twin needle gizmos we first saw twenty years ago.

Breg, Inc., has announced the appointment of Stuart M. Essig as chairman of the board. Mr. Essig retired from the position of Chief Executive Officer at Integra LifeSciences Holdings Corporation earlier this year.

Corin Group must be doing something right for LARS SA to extend its distribution agreement with the company in terms of both time and territories. Most notably the new deal now encompasses USA, subject to Corin handling the 510(k) submission.

Orthofix’s foray into bracing and cold therapy is over with its announcement that it’s selling Breg, acquired in 2003.

MedShape’s Chairman and CEO tells us more about the success of the company’s products, especially its ExoShape ACL tibial graft fixation device, and plans for a European launch.

Dynatron Quad7 is a cool name for what Dynatronics claims is a cool product. It’s new device avoids the need for ice in delivery of cold therapy for sports medicine and physical therapy.

Orthofix’s financials are solid if unspectacular with healthy revenue growth in orthopaedics and sports medicine its shining stars.

Self-Tightening Sports Footwear had its origins in angioplasty catheter guidance mechanisms. Now the company is back in medical devices with brace collaborations.

Meniscal transplantation gets an airing at AAOS

Arthrex relies on surgeon training in “wet labs” as a major tool in its marketing mix. Now the company has overcome objection from locals in Vail and gained permission to finish building such a facility.